REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular

E-ISSN： 1875-6190|14|1|28-40

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.1, 2016-01, pp. : 28-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

REM Sleep Behavior Disorder and Narcolepsy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 4, 2009-08 ,pp. : 264-270

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapies to Manage Bone Loss-Associated Diseases: A Quest for the Perfect Benefit-to-Risk Ratio

Current Medicinal Chemistry, Vol. 15, Iss. 3, 2008-02 ,pp. : 284-304

Bentham Science Publishers

Access to resources Recommend Favorite

Differential effects of acidosis, high potassium concentrations, and metabolic inhibition on noradrenaline release and its presynaptic muscarinic regulation

By Haunstetter A. Schulze Icking B. Backs J. Krüger C. Haass M.

Pharmacological Research, Vol. 45, Iss. 3, 2002-03 ,pp. : 221-228

Academic Press

Access to resources Recommend Favorite

Neuroplasticity Regulation by Noradrenaline in Mammalian Brain

Current Neuropharmacology, Vol. 7, Iss. 4, 2009-12 ,pp. : 286-295

Bentham Science Publishers

Access to resources Recommend Favorite

Fluoxetine: REM sleep behaviour disorder: case report

Reactions Weekly, Vol. 1, Iss. 1284, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite